Immunomodulatory role of prolactin in diabetes development
Authors:
- 1 September 2009
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 9 (1) , 23-27
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- B‐lymphocyte contributions to human autoimmune diseaseImmunological Reviews, 2008
- B cell autonomous TLR signaling and autoimmunityAutoimmunity Reviews, 2008
- Extrapituitary prolactin promoter polymorphism in Czech patients with systemic lupus erythematosus and rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Modulation of prolactin expression in human T lymphocytes by cytokinesJournal of Neuroimmunology, 2005
- Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancyJournal of Endocrinology, 2004
- Serum prolactin stress values in patients with systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2003
- Prolactin and autoimmunityAutoimmunity Reviews, 2002
- Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitorsExperimental Hematology, 2001
- Suppressors of Cytokine Signaling-1 and -6 Associate with and Inhibit the Insulin ReceptorJournal of Biological Chemistry, 2001
- Differential effects of proclatic upon activation and differentiation of human B lymphocytesJournal of Neuroimmunology, 1993